Skip to main content
. 2021 Apr 29;1:639349. doi: 10.3389/fbinf.2021.639349

TABLE 2.

Twenty-four drugs used in the proposed model.

Afatinib Crizotinib Dabrafenib Daporinad Dasatinib Erlotinib
Gefitinib Lapatinib Leflunomide Linsitinib MK-1775 Navitoclax
Nilotinib Osimertinib Palbociclib Ribociclib Ruxolitinib Sorafenib
Staurosporine Tamoxifen Trametinib Ulixertinib Vinblastine Vorinostat